Concepedia

Kay Tetzlaff

KT

Statistics

Publications

35

Citations

7.2K

H-Index

25

Active since

1999

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Tübingen

Boehringer Ingelheim (United States)

German Center for Lung Research

University of Colorado Denver

Kay Tetzlaff is an author at Boehringer Ingelheim (Germany) specializing in pulmonology, medicine, and chronic obstructive pulmonary disease.

ORCID

Publications per year

1999–2023

35

Publications

35

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +11

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

, , +13

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

H Magnussen, Bernd Disse, Roberto Rodríguez-Roisin et al. · New England Journal of Medicine · 2014 · 621 citations · Full text

, , +17

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

Henrik Watz, Kay Tetzlaff, Emiel F.�M. Wouters et al. · The Lancet Respiratory Medicine · 2016 · 421 citations · Full text

, , +17

Trial of Spesolimab for Generalized Pustular Psoriasis

H. Bachelez, Siew Eng Choon, Slaheddine Marrakchi et al. · New England Journal of Medicine · 2021 · 337 citations · Full text

, , +15

1–5 of 35